Track 8: Pharmacovigilance

Pharmacovigilance focuses on the continuous monitoring and evaluation of medicine safety throughout the product lifecycle. Topics include adverse drug reactions, signal detection, risk assessment, safety databases, post-marketing surveillance, and risk-management strategies. Researchers can explore real-world evidence, electronic health records, patient-reported outcomes, and advanced data-mining approaches for identifying safety signals. Artificial intelligence and machine learning applications for processing large-scale safety data are also highly relevant. The track highlights strategies for detecting previously unrecognized risks and improving medication safety. Innovative pharmacovigilance approaches that strengthen patient protection and regulatory decision-making are encouraged.

 

    Related Conference of Track 8: Pharmacovigilance

    September 24-25, 2026

    6th World Congress on Rare Diseases & Orphan Drugs

    Paris, France
    November 26-27, 2026

    5th World Congress on Precision and Personalized Medicine

    Zurich, Switzerland
    November 26-27, 2026

    5th World Conference on Pharma Industry and Medical Devices

    Zurich, Switzerland
    December 14-15, 2026

    5th Global Summit on Pharmaceutical Research

    Paris, France
    January 26-27, 2027

    22nd Annual Meet on Pharmaceutical Sciences

    Paris, France
    February 15-16, 2027

    23rd Annual Congress on Pharmacology and Toxicology

    Paris, France
    February 22-23, 2027

    41st World Congress on Pharmacology and Therapeutics

    Amsterdam, Netherlands
    April 08-09, 2027

    21st World Drug Delivery Summit

    Vienna, Austria
    April 27-28, 2027

    10th European Biopharma Congress

    Paris, France
    April 27-28, 2027

    19th World Drug Delivery Summit

    Paris, France

    Track 8: Pharmacovigilance Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in